Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8751319 | Virology | 2018 | 12 Pages |
Abstract
Human myxovirus resistance protein B (hMXB) is a restriction factor of HIV-1 that also inhibits a variety of retroviruses. However, hMXB is not antiviral against equine infectious anemia virus (EIAV). We show here that equine MX2 (eMX2) potently restricts EIAV in vitro. Additionally, eMX2 inhibits HIV-1 and other lentiviruses, including murine leukemia virus. Previously, it was reported that hMXB repression is reduced in hMXB Î1-25, but not in GTP-binding mutant K131A and GTP-hydrolysis mutant T151A. In contrast to this phenomenon, our study indicates that eMX2 restriction is not diminished in eMX2 Î1-25, but is in eMX2 K127A and T147A, which correspond to hMXB K131A and T151A, respectively. Thus, eMX2 may inhibit retroviral replication by a novel mechanism that differs from that of hMXB.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Kristina Meier, Ananda Ayyappan Jaguva Vasudevan, Zeli Zhang, Ariane Bähr, Georg Kochs, Dieter Häussinger, Carsten Münk,